1,158
Views
0
CrossRef citations to date
0
Altmetric
Inner ear

Efficacy of transtympanic infusion of dexamethasone into the tympanic cavity in mice with acute sensorineural hearing loss associated with cytomegalovirus infection

ORCID Icon, , , &
Pages 647-652 | Received 09 Mar 2022, Accepted 06 May 2022, Published online: 15 Sep 2022

References

  • Morton CC, Nance WE. Newborn hearing screening-a silent revolution. N Engl J Med. 2006;354(20):2151–2164.
  • Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the Central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16–25.
  • Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: Comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg. 2000;122:521–528.
  • Zhao D, Tong B, Wang Q, et al. A comparison of effects of systemic and intratympanic steroid therapies for sudden sensorineural hearing loss: a Meta-analysis. J Otol. 2016;11(1):18–23.
  • Han MA, Back SA, Kim HL, et al. Therapeutic effect of dexamethasone for noise-induced hearing loss: Systemic versus intratympanic injection in mice. Otol Neurotol. 2015;36(5):755–762.
  • Ramaswamy B, Roy S, Apolo AB, et al. Magnetic nanoparticle mediated steroid delivery mitigates cisplatin induced hearing loss. Front Cell Neurosci. 2017;11:268.
  • Ikuta K, Ogawa H, Hashimoto H, et al. Restricted infection of murine cytomegalovirus (MCMV) in neonatal mice with MCMV-induced sensorineural hearing loss. J Clin Virol. 2015;69:138–145.
  • Friedman TB, Sellers JR, Avraham KB. Unconventional myosins and the genetics of hearing loss. Am J Med Genet. 1999;89(3):147–157.
  • Zhuang W, Wang C, Shi X, et al. MCMV triggers ROS/NLRP3-associated inflammasome activation in the inner ear of mice and cultured spiral ganglion neurons, contributing to sensorineural hearing loss. Int J Mol Med. 2018;41(6):3448–3456.
  • Rarey KE, Luttge WG. Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res. 1989;41(2-3):217–222.
  • Lyu AR, Kim DH, Seung LH, et al. Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: a comparison of administration routes. PLoS One. 2018;13(3):e0195230.
  • Nyberg S, Abbott NJ, Shi X, et al. Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier. Sci Transl Med. 2019;11:eaao0935.
  • Kordiš Š, Battelino S. The role of high dose intratympanic dexamethasone as salvage therapy for idiopathic sudden sensorineural hearing loss. J Int Adv Otol. 2017;13(3):318–321.
  • Fujioka M, Kanzaki S, Okano HJ, et al. Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res. 2006;83(4):575–583.
  • Masuda M, Nagashima R, Kanzaki S, et al. Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation. Brain Res. 2006;1068(1):237–247.
  • Kanzaki S, Sakagami M, Hosoi H, et al. High fibrinogen in peripheral blood correlates with poorer hearing recovery in idiopathic sudden sensorineural hearing loss. PLoS One. 2014;9(8):e104680.
  • Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol. 1998;19:230–235.
  • Umaru B, Pyriochou A, Kotsikoris V, et al. ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo. J Pharmacol Exp Ther. 2015;354(1):79–87.
  • Suzuki M, Yamasoba T, Kaga K. Development of the blood-labyrinth barrier in the rat. Hear Res. 1998;116(1-2):107–112.
  • Ikuta K, Suzutani T. Congenital cytomegarovirus infection and hearing loss. Fukushima Med J. 2017;67:7–15. (In Japanese)